OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis
Keyu Kong, Yongyun Chang, Hua Qiao, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Delivery of FGF18 using mRNA-LNP protects the cartilage against degeneration via alleviating chondrocyte senescence
Keyu Kong, Baixing Li, Yongyun Chang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

SIRT6 inhibits endoplasmic reticulum stress-mediated ferroptosis by activating Nrf2/HO-1 signaling to alleviate osteoarthritis
Jiaqi Shi, Li Chen, Xu Wang, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access

Deferoxamine alleviates chondrocyte senescence and osteoarthritis progression by maintaining iron homeostasis
Zhou Guo, Yang Lin, Haigang Liu, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112619-112619
Closed Access | Times Cited: 4

A Ubiquitin‐Competitive Strategy Based on the Element Microenvironment to Treat Osteoarthritis
Keyu Kong, Yuqi Yang, Yongyun Chang, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3

Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19
Yiwei Zhang, Zhengwei Duan, Yonghao Guan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Paxlovid
Niraj Niraj, Sonia Mahajan, Ajay Prakash, et al.
Indian Journal of Pharmacology (2022) Vol. 54, Iss. 6, pp. 452-458
Open Access | Times Cited: 15

From docking to dynamics: Unveiling the potential non-peptide and non-covalent inhibitors of Mpro from natural products
Xin Zhang, Shulin Zhao, Xi Su, et al.
Computers in Biology and Medicine (2024) Vol. 181, pp. 108963-108963
Closed Access | Times Cited: 1

Clinical Features and Predictive Nomogram for Fatigue Sequelae in Non-severe Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai, China
Xiaolei Shen, Yuhan Jiang, Shenjie Li, et al.
Brain Behavior & Immunity - Health (2024) Vol. 42, pp. 100889-100889
Open Access | Times Cited: 1

Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?
Shania Bieri, Burkhard Möller, Jennifer Amsler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8212-8212
Open Access | Times Cited: 1

In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16392-16392
Open Access | Times Cited: 2

Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa E. C. Constant, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Development and Approval of a Multidimensional Model of the Clinical Effectiveness of Treatment Technologies for Patients With a Mild COVID-19 Associated With Comorbidities
О.К. Yakovenko, Serhii O. Soloviov, MykhailoP Smetiukh, et al.
Innovative Biosystems and Bioengineering (2024) Vol. 8, Iss. 1, pp. 19-36
Open Access

Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants
Pasquale Pagliano, Anna Maria Spera, Carmine Sellitto, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1301-1311
Closed Access | Times Cited: 1

CLINICAL EFFICACY AND SAFETY OF AMINOCAPROIC ACID IN THE TREATMENT OF PATIENTS WITH MILD COVID-19 AND THE PRESENCE OF RISK FACTORS FOR DISEASE PROGRESSION
O. К. Yakovenkо, Oleksandr Dziublyk, G. B. Kapitan, et al.
Ukrainian Pulmonology Journal (2023) Vol. 31, Iss. 3, pp. 27-32
Open Access

The implications of oxidative stress in long COVID pathogenesis
Vesna Ćorić
Medicinski podmladak (2023) Vol. 74, Iss. 4, pp. 6-14
Open Access

Page 1

Scroll to top